Medicure Inc (TSE:MPH) has released an update.
Medicure Inc., a pharmaceutical firm with a focus on the U.S. cardiovascular market, has announced it will present its 2023 financial results during a webcasted conference call on April 9, 2024. The results, which will be filed on April 8, will be discussed by management, who will also address questions in a Q&A session. The company is known for products like AGGRASTAT and ZYPITAMAG and operates the Marley Drug pharmacy.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.
